Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exact Sciences Corp (NASDAQ:EXAS)

39.17
Delayed Data
As of Jul 21
 +0.13 / +0.33%
Today’s Change
11.96
Today|||52-Week Range
39.99
+193.19%
Year-to-Date
Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?
Jul 21 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for July 17th
Jul 17 / Zacks.com - Paid Partner Content
Why Exact Sciences (EXAS) Might Surprise This Earnings Season
Jul 21 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Alimera Sciences, Enzo Bio...
Jul 12 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for July 19th
Jul 19 / Zacks.com - Paid Partner Content
5 Top Multibagger Biotech Stocks to Buy in the 2nd Half
Jul 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close39.04
Today’s open39.11
Day’s range38.71 - 39.33
Volume1,069,630
Average volume (3 months)3,044,844
Market cap$4.6B
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)+4.68%
Earnings growth (this year)+18.98%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+151.99%
P/E ratioNM
Price/Sales13.76
Price/Book12.88

Competitors

 Today’s
change
Today’s
% change
TECHBio-Techne Corp+1.05+0.90%
BLUEbluebird bio Inc+0.25+0.26%
NBIXNeurocrine Bioscienc...-0.72-1.51%
NKTRNektar Therapeutics+0.07+0.32%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$99.4M
Annual profit (last year)-$167.2M
Net profit margin-168.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts